Status:
UNKNOWN
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Collaborating Sponsors:
Tumor Study Group Head and Neck
Conditions:
Oral Cancer
Oropharynx Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is no consensus on the indication of postoperative radiotherapy for early stages oral and oropharyngeal squamous cell carcinoma with complete pathological resection and no neck node metastasis, ...
Eligibility Criteria
Inclusion
- Oral and oropharynx (exclusion vallecula) squamous cell carcinoma
- T1 or T2
- unique, untreated tumor
- N0 or nodes \<3cm
- complete pathological resection
- no perineural spread, vascular emboli \<5
- pN0 or \<=2N+R-
- signed inform consent
Exclusion
- Vallecula carcinoma
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT00232960
Start Date
October 1 2005
End Date
June 1 2014
Last Update
March 28 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Francois Baclesse
Caen, France, 14000
2
Hôpital de la Croix Rousse
Lyon, France
3
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France, 54511
4
Institut Gustave Roussy
Villejuif, France, 94800